AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 41 filers reported holding AGILE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $79,000 | -75.5% | 160,980 | -52.1% | 0.01% | -78.3% |
| Q3 2021 | $322,000 | -30.6% | 335,735 | -3.8% | 0.05% | -25.8% |
| Q2 2021 | $464,000 | -61.5% | 349,158 | -39.7% | 0.06% | -62.7% |
| Q1 2021 | $1,204,000 | -53.1% | 578,864 | -35.3% | 0.17% | -55.4% |
| Q4 2020 | $2,569,000 | -11.0% | 895,166 | -5.6% | 0.37% | -17.5% |
| Q3 2020 | $2,885,000 | +10.4% | 948,729 | +0.9% | 0.45% | +5.9% |
| Q2 2020 | $2,613,000 | +197.9% | 940,197 | +99.3% | 0.43% | +166.2% |
| Q1 2020 | $877,000 | – | 471,633 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |